From mechanism of action to the dossier that supports it
BiCT is the R&D laboratory of companies that develop branded ingredients and actives, and of those bringing own-brand supplements to market. We work on the mechanism with multi-model in vitro studies, on the stability and bioaccessibility of the active, and on benchmarking against category references under the same conditions. Not isolated tests: the experimental design that supports what the product claims.
Let's talk about your project
Who we work for
Two clients, one scientific platform.
Ingredient & branded active companies
Producers of bioactive ingredients obtained through biotechnological processes such as fermentation, and of extracts. You need scientific evidence and dossiers to position your active on global B2B markets.
What you are looking for: mechanism-of-action validation · comparative efficacy validation vs top sellers · stability, bioaccessibility and bioavailability testing · analytical method development · publication or patent · guiding or strengthening clinical trials · dossiers and communication for your sales force and for the customers who develop the finished product.
Finished-product supplement companies
Nutraceutical brands, contract manufacturers and distributors launching new lines or strengthening existing ones. You need distinctive products, evidence and a scientific narrative for your sales force.
What you are looking for: differentiating concepts · multi-model in vitro studies · stability, bioaccessibility and bioavailability testing · competitor benchmarking · analytical method development · guiding or strengthening clinical trials · building a technical dossier · publication or patent.
A nutraceutical claim is defended with data
Regulation EC 1924/2006 governs what a supplement may state on its label, and the perimeter of authorised claims is narrow. What falls outside it — mechanism, bioaccessibility, benchmarking against references — never reaches the pack, but it decides the technical conversation: with the formulator downstream, with the buyer, with the doctor and the pharmacist.
Without data of your own, that conversation is held in your competitor's words.
What we solve
Four points at which a nutraceutical project stalls, and the data that gets it moving again.
How we work: three paths to your objective
We do not sell single tests: the plan is built on the claim you need to support and on the reader who will have to accept it.
Ingredient validation and valorisation
For ingredient companies.
We translate bioactivity into evidence your downstream customers can adopt: a technical and commercial dossier, a scientific publication, a patent.
Supplement valorisation and formulation development
For ingredient and finished-product companies.
We move formulation from a marketing choice to a scientific one — including validation of biological efficacy on the final formulation, not only on the isolated ingredient.
New ingredient development
An additional capability.
When innovation calls for a new ingredient, we develop the underlying process — from fermentation or extraction through to prototype — for those who want to own the scientific and manufacturing base.
Where the data is used
A technical dossier has more than one reader: these are the ones we write it for.
Where do we start?
I am an ingredient company
I am a finished-product company
I am not sure where to start
Insights
Technical articles from the division: what has to be demonstrated, how it is measured and what it costs, with data from our own projects.
S-acetyl glutathione: what the EFSA opinion actually saysEFSA has given its safety opinion on S-acetyl glutathione as a novel food. An opinion is not an authorisation, and the months still to run before […]Read →
Lactoferrin: what changes from one form to anotherLactoferrin is one molecule with many commercial forms, and the forms are not equivalent. That is why two supplements declaring the same ingredient can behave differently, […]Read →
Not every ingredient needs a clinical studyEvery company wants clinical evidence. Not every project is ready for it. The question worth asking before opening a budget for a human study is more […]Read →Projects we can talk about
Some of the projects we have worked on with companies and research centres.
SmartNutriHealth2Development of a Center of Excellence for Sustainable Research on Innovative Nutraceuticals in a 4.0 Framework.Read →
PRO-MINDEffect of Probiotics on Depressive Symptoms in Patients with Disorders of Gut-Brain Interaction.Read →
InnoFeedA project aimed to develop products with selected heat-inactivated micro-organisms that can be used as a raw material with prebiotic properties for animal nutrition.Read →
ScidaThe SCIDA project is oriented towards the development and validation of new pre- and probiotic products for the prevention and treatment of IBS and AD.Read →Tell us about the active and what it has to demonstrate
From the district it acts on and the claim you need to support, we derive the models, the endpoints and the shape of the dossier. That is exactly what the first conversation is for.
Contact us